AI models need more data about biology, and OpenAI is paying to create it
Source:
mitTechReview
September 15, 2026 · 05:00
From the publisher
Last year, the clinical trial policy analyst Ruxandra Teslo posted an idea for super-charging medical AI systems: use data from failed biotech companies. By bidding at their bankruptcy proceedings, she proposed, it might be possible to obtain detailed regulatory filings, manufacturing strategies, and safety data—information usually kept hidden as valuable trade secrets. She called these…
The original article opens on the publisher's website.
More from General
View topic →Yield on 10-year Treasury hovers above 5% as investors await Fed decision
cnbc
Sep 16, 2026 · 01:58
‘Smart’ Nanoparticles Deliver mRNA Directly to Tumors in New Cancer Therapy
wired
Sep 16, 2026 · 01:30
Canada could become 'first associate member' of EU, bloc's chief says
cnbc
Sep 16, 2026 · 01:21
Age Limits for Social Media Outlined by European Union
nytimes
Sep 16, 2026 · 01:20
Ethereum, Base give up on common wallet standard after months of talks
coinDesk
Sep 16, 2026 · 01:07